What are you looking for today?

Sbirkov, Yordan, Ivanova, Tsvetomira, Burnusuzov, Hasan, Gercheva, Kalina, Petrie, Kevin, Schenk, Tino and Sarafian, Victoria (2021) The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows In Vitro Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia. Frontiers in oncology, 11. p. 632181. ISSN 2234-943X

Document

Abstract

Abstract

Childhood acute lymphoblastic leukaemia (cALL) accounts for about one third of all paediatric malignancies making it the most common cancer in children. Alterations in tumour cell metabolism were first described nearly a century ago and have been acknowledged as one of the key characteristics of cancers including cALL. Two of the backbone chemotherapeutic agents in the treatment of this disease, Glucocorticoids and L-asparaginase, are exerting their anti-leukaemic effects through targeting cell metabolism. Even though risk stratification and treatment regimens have improved cure rates to nearly 90%, prognosis for relapsed children remains poor. Therefore, new therapeutic approaches are urgently required. Atovaquone is a well-tolerated drug used in the clinic mainly against malaria. Being a ubiquinone analogue, this drug inhibits co-enzyme Q10 of the electron transport chain (ETC) affecting oxidative phosphorylation and cell metabolism. In this study we tested the effect of Atovaquone on cALL cells . Pharmacologically relevant concentrations of the inhibitor could effectively target mitochondrial respiration in both cALL cell lines (REH and Sup-B15) and primary patient samples. We found that Atovaquone leads to a marked decrease in basal respiration and ATP levels, as well as reduced proliferation, cell cycle arrest, and induction of apoptosis. Importantly, we observed an enhanced anti-leukaemic effect when Atovaquone was combined with the standard chemotherapeutic Idarubicin, or with Prednisolone in an model of Glucocorticoid resistance. Repurposing of this clinically approved inhibitor renders further investigations, but also presents opportunities for fast-track trials as a single agent or in combination with standard chemotherapeutics. [Abstract copyright: Copyright © 2021 Sbirkov, Ivanova, Burnusuzov, Gercheva, Petrie, Schenk and Sarafian.]

Item Type: Article
Uncontrolled Keywords: acute B-cell lymphoblastic leukaemia, atovaquone, glucocorticoid resistance, metabolism, mitochondria
SWORD Depositor: Publication Router
Depositing User: Kevin Petrie
URI: https://sure.sunderland.ac.uk/id/eprint/13368

Further Details

More Information

Uncontrolled Keywords
acute B-cell lymphoblastic leukaemia, atovaquone, glucocorticoid resistance, metabolism, mitochondria
SWORD Depositor
Depositing User

Identifiers

Item ID
13368
Identification Number
ISSN
2234-943X

Users with ORCIDS

ORCID for Kevin Petrie

Catalogue record

Date Deposited
26 Apr 2021 16:16
Last Modified
04 Jun 2025 16:29

Contributors

Author
Yordan Sbirkov
Author
Tsvetomira Ivanova
Author
Hasan Burnusuzov
Author
Kalina Gercheva
Author
Tino Schenk
Author
Victoria Sarafian

University Divisions

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year